Stria Lithium Inc. (SRCAF)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | 12.02 | 16.43 Thousand |
| Gross Profit | - | - | - | - | -12.02 | -16.43 Thousand |
| Operating Expenses | 1.53 Million | 1.27 Million | 374.81 Thousand | 161.3 Thousand | 240.79 Thousand | 358.39 Thousand |
| Selling, General and Administrative Expenses | 1.53 Million | 1.26 Million | 345.01 Thousand | 148.08 Thousand | 212.96 Thousand | 319.25 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 2500.00 | -29.79 Thousand | 180.79 Thousand | -10.96 Thousand | -30.89 Thousand |
| Cost and Expenses | 1.53 Million | 1.27 Million | 374.81 Thousand | 161.3 Thousand | 240.79 Thousand | 358.39 Thousand |
| Operating Income | -1.53 Million | -1.27 Million | -374.81 Thousand | -161.3 Thousand | -240.79 Thousand | -358.39 Thousand |
| Interest Expense | - | 60.61 Thousand | 64.38 Thousand | - | - | - |
| Income Tax Expense | - | 61.86 Thousand | 34.26 Thousand | -119.93 | -11.37 Thousand | -192.06 Thousand |
| Earnings before Tax | -1.23 Million | -1.33 Million | -439.19 Thousand | 19.49 Thousand | -240.58 Thousand | -358.37 Thousand |
| Net Income | -1.23 Million | -1.33 Million | -439.19 Thousand | 19.49 Thousand | -240.58 Thousand | -358.37 Thousand |
| Earnings Per Share Basic | -0.05 | -0.08 | -0.05 | 0.00 | -0.03 | -0.06 |
| Earnings Per Share Diluted | -0.05 | -0.08 | -0.05 | 0.00 | -0.03 | -0.06 |
| Weighted Average Shares Outstanding | 25.21 Million | 16.33 Million | 9.3 Million | 7.24 Million | 7.02 Million | 5.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.21 Million | 16.33 Million | 9.3 Million | 7.24 Million | 7.02 Million | 5.95 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.56 Million | - | - | - | - | - |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 164.79 Thousand | 168.03 Thousand | 243.79 Thousand | 226.44 Thousand | 1.64 Million | 705.51 Thousand |
| Selling, General and Administrative Expenses | 164.79 Thousand | 168.03 Thousand | 243.79 Thousand | 118.29 Thousand | - | 677.88 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 19.17 Thousand | - | - | - | - | - |
| Cost and Expenses | 164.79 Thousand | 168.03 Thousand | 243.79 Thousand | 226.44 Thousand | 1.64 Million | 705.51 Thousand |
| Operating Income | -164.8 Thousand | -168.03 Thousand | -243.79 Thousand | 142.74 Thousand | -1.56 Million | -686.14 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -133.36 Thousand | -160.03 Thousand | -237.72 | 354.52 Thousand | -1533.44 | -1221.88 |
| Earnings before Tax | -631.64 Thousand | -872.95 Thousand | -416.77 Thousand | 142.74 Thousand | -1.23 Million | -686.14 Thousand |
| Net Income | -631.64 Thousand | -872.95 Thousand | -416.77 Thousand | 142.74 Thousand | -1.23 Million | -686.14 Thousand |
| Earnings Per Share Basic | -0.02 | -0.03 | -0.02 | 0.01 | - | -0.03 |
| Earnings Per Share Diluted | -0.02 | -0.03 | -0.02 | 0.01 | - | -0.03 |
| Weighted Average Shares Outstanding | 25.92 Million | 25.92 Million | 25.92 Million | 25.92 Million | 25.21 Million | 25.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.92 Million | 25.92 Million | 25.92 Million | 25.92 Million | 25.21 Million | 25.64 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -164.8 Thousand | -168.03 Thousand | -243.79 Thousand | 142.74 Thousand | - | -686.14 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
8585
BCBC
EDNMY
CCG
SICAGEN
2351